Evaluation
Question 1: How are DP18-1805 TTA providers implementing the
components of the NOFO to build capacity among their target
audience(s)?
|
EQ
1A.
To what
extent did DP18-1805 TTA providers implement the components of
the NOFO to build capacity among their target audience?
|
Description
of activities related to the core strategies of the NOFO:
approaches
Training
curriculum
Webinar
topics
Product
development plan
#
and type of TTA provided in terms of dose,
frequency,
intensity, and mode (e.g., in person, group, one on one,
virtual, website)
#
and type of materials and/or products developed (e.g.,
webinars, presentations,
podcasts,
guidance documents, fact sheets, newsletters)
#
and type of channels used to disseminate
evidence-based
interventions and/or
promising
practices
Development
of evaluation plan
Collection
of evaluation data
|
Program
materials (e.g., work plans, progress reports, evaluation
reports, program logic models)
Interviews
with organizational staff that support the implementation of
DP18-1805 conducted via case studies
|
|
EQ
1B. What factors affect TTA providers’ implementation of
DP18-1805 NOFO components?
|
History
Maturity
Mission
Leadership
|
Program
materials (e.g., work plans, progress reports, evaluation
reports, program logic models)
Interviews
with organizational staff that support the implementation of
DP18-1805 conducted via case studies
|
|
Evaluation
Questions 2: To what extent did DP18-1805 TTA providers achieve
planned short-term outcomes?
|
2A.
To what extent did DP18-1805 funded organizations achieve
short-term, TTA provider-specific outcomes?
|
Evidence
of reduced duplication of TTA efforts among TTA provider
Evidence
of quality and accessibly of TTA materials (e.g., public
education trainings, evaluation tools, and resources)
|
|
Thematic
analysis
Descriptive
analysis
|
2B.
To what extent did
DP18-1805 funded organizations’ TTA activities contribute
to TTA consumers’ achievement in short-term outcomes?
|
#
of CCC programs that report the development of partnerships for
cancer prevention, screening, and survivorship
#
of CCC programs that report implementation
of
evidence-based interventions
#
of CCC programs that report use of health system; policy,
systems, and environmental; and community clinical linkage
strategies
#
of CCC programs that report use of rigorous evaluation by NCCCP
grantees
|
Program
materials review
Interviews
with organizational staff that support the implementation of
DP18-1805 conducted via case studies
Survey
of NCCCP program directors, coalition members, and/or partners
|
Thematic
analysis
Descriptive
analysis
|
Evaluation
Questions 3: To what extent did DP18-1805 funded organization
TTA activities contribute to NCCCP implementation and
achievement in NCCCP priorities and goals?
|
3A.
To what extent did DP18-1805 funded organizations’ TTA
activities contribute to TTA consumers’ achievement in
intermediate and longer term outcomes?
|
#
of CCC programs that report an improved ability to leverage
resource and sustained implementation of CCC activities
#
of CCC programs that report sustained use of evaluation for
program improvement
#
of CCC programs that continued use of evidenced-based
approaches for cancer prevention and control
|
|
|
EQ
3B. How do key stakeholders from DP18-1805 perceive the
effectiveness of TTA in contributing to NCCCP implementation and
achievement in NCCCP goals?
|
#
and type of individuals’ perceptions of the overall
effectiveness of the TTA
#
and type of individuals’ perceptions of the most
effective aspects of the TTA provided
#
and type of individuals’ perceptions of the least
effective aspects of the TTA
#
and type of individuals’ suggestions for improving the
effectiveness of each TTA provider
|
Program
materials review
Interviews
with organizational staff that support the implementation of
DP18-1805 conducted via case studies
Survey
of NCCCP program directors, coalition members, and/or partners
|
Thematic
analysis
Descriptive
analysis
|
Evaluation
Question 4: What elements of TTA were most effective in building
the capacity of NCCCP programs?
|
4A.
Which, if any, of the TTA approaches, strategies or activities
implemented under DP18-1805 contributed the most to improved
NCCCP programmatic capacity and/or outcomes?
|
#,
type, and content of the DP18-1805 funded organizations’
TTA approaches, strategies, and/or activities that result in
the most improved outcomes
#,
type, and content of the DP18-1805 funded organizations’
TTA approaches, strategies, and/or activities
#,
type, and content of the DP18-1805 funded organizations’
TTA approaches, strategies, and/or activities CDC staff and
national organizations
consider
core/essential
|
Interviews
with organizational staff that support the implementation of
DP18-1805 conducted via case studies
Survey
of CCC program director, coalition chair and up to 3 partners
per program
|
Thematic
analysis
Descriptive
analysis
|
4B.
What contextual factors influenced the effectiveness of the TTA?
|
Characteristics
related to the design of the DP18-1805 cooperative agreement
Organizational
characteristics of DP18-1805 funded organizations
Characteristics
of the NCCCP grantees
Characteristics
of NCCCP coalition members and Partners
Demographic
or behavioral characteristics of specific populations/audiences
|
Program
materials review
Interviews
with organizational staff that support the implementation of
DP18-1805 conducted via case studies
Survey
of NCCCP program directors, coalition members, and/or partners
|
Thematic
analysis
Descriptive
analysis
|